Atypical Ebola Virus Disease in a Nonhuman Primate following Monoclonal Antibody Treatment Is Associated with Glycoprotein Mutations within the Fusion Loop
Ebola virus remains a global threat to public health and biosecurity, yet we still know relatively little about its pathogenesis and the complications that arise following recovery. With nearly 20,000 survivors from the 2013–2016 West African outbreak, as well as over 1,000 survivors of the recent...
Guardado en:
Autores principales: | Logan Banadyga, Wenjun Zhu, Shweta Kailasan, Katie A. Howell, Krzysztof Franaszek, Shihua He, Vinayakumar Siragam, Keding Cheng, Feihu Yan, Estella Moffat, Wenguang Cao, Anders Leung, Carissa Embury-Hyatt, M. Javad Aman, Xiangguo Qiu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/909040b19d774466a013d0a904fb9c04 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Post-exposure immunotherapy for two ebolaviruses and Marburg virus in nonhuman primates
por: Jennifer M. Brannan, et al.
Publicado: (2019) -
Nonhuman primate to human immunobridging to infer the protective effect of an Ebola virus vaccine candidate
por: Ramon Roozendaal, et al.
Publicado: (2020) -
Nonhuman and Human 'Victims' and 'Perpetrators': Intra-active InSecurity Becomings of the Ebola Outbreak
por: Theresa Ammann
Publicado: (2018) -
Ebola viral dynamics in nonhuman primates provides insights into virus immuno-pathogenesis and antiviral strategies
por: Vincent Madelain, et al.
Publicado: (2018) -
Ebola virus VP24 interacts with NP to facilitate nucleocapsid assembly and genome packaging
por: Logan Banadyga, et al.
Publicado: (2017)